Watson buys Stride's Australia Business

Watson Pharmaceuticals expanded its reach in the Asia-Pacific with a deal to buy Strides Arcolab's Australia-based generics business,( Ascent Pharmahealth) . The buyout not only gives Watson a major presence in Australia, where it becomes the fifth-largest  generic drugmaker, but it also  a  No. 1  position in Singapore.